This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

Angel Biotechnology Holdings plc. (ABH) SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about Angel Biotechnology Holdings plc. (ABH) operations to identify potential customers, partners and suppliers. Angel Biotechnology Holdings plc. (ABH) business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Table Of Contents


Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Deals By Year, from 2005 to 2011 4
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare Deals By Type, from 2005 to 2011 5
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal By Region, from 2005 to 2011 6
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal Summary, from 2005 to 2011 7
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal Details 8
Equity Offering 8
Angel Biotechnology Completes Private Placement For US$ 2 Mln 8
Angel Biotechnology Completes Private Placement Of US$ 8 Mln 10
Angel Biotechnology Completes Private Placement Of US$ 2.1 Mln 11
Angel Biotechnology Completes Private Placement Of US$ 0.1 Mln 12
Angel Biotechnology Raises US$ 2.6 Mln From Exercise Of Warrants 13
Angel Biotechnology Raises US$ 2.5 Mln From Exercise Of Warrants 14
Angel Biotechnology Completes Private Placement US$ 0.1 Mln 15
Angel Biotechnology Completes Private Placement Of US$ 1.2 Mln 16
Angel Biotechnology Completes Private Placement Of US$ 1.13 Mln 17
Angel Biotechnology Completes Private Placement Of US$ 2.6 Mln 18
Key Competitors 19
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations and Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
November 09, 2010: Angel Plans To Increase Manufacturing Capacity 21
May 24, 2010: Angel Signs Three Contracts With Materia Medica 21
Financial Announcements 22
June 11, 2009: Angel Biotechnology Reports Net Income Of British Pound 1.08 Mln For 2008 22
September 26, 2008: Interims Results For The Six Month Period Ended 30 June e 2008 22
June 30, 2008: Angel Biotechnology Holdings Plc (The Firms ) Publication Of Annual Report And Accounts 23
September 22, 2006: Interim Results 24
May 26, 2006: Angel Biotechnology Holdings Plc Preliminary Results Announcement For The Year Ended 31st December ember 2005 25
Research And Development 27
March 18, 2010: Angel Signs GMP Contracts With ReNeuron 27
Corporate Communications 27
July 07, 2010: Angel Biotechnology Appoints Lorna Peers As Group Financial Controller And Firms Secretary 27
January 09, 2009: Angel Biotechnology's Board Member Javier Fernandez Resigns 28
Government and Public Interest 28
November 16, 2010: Angel Biotechnology Manufactures Stem Cells Used In Clinical Trial For Stroke Patients 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29


List of Tables

Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Major development, 2009 1
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Deals By Year, from 2005 to 2011 1
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal By Region, from 2005 to 2011 1
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Deals By Year, from 2005 to 2011 4
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare Deals By Type, from 2005 to 2011 5
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal By Region, from 2005 to 2011 6
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal Summary, from 2005 to 2011 7
Angel Biotechnology Completes Private Placement For US$ 2 Mln 8
Angel Biotechnology Completes Private Placement Of US$ 8 Mln 10
Angel Biotechnology Completes Private Placement Of US$ 2.1 Mln 11
Angel Biotechnology Completes Private Placement Of US$ 0.1 Mln 12
Angel Biotechnology Raises US$ 2.6 Mln From Exercise Of Warrants 13
Angel Biotechnology Raises US$ 2.5 Mln From Exercise Of Warrants 14
Angel Biotechnology Completes Private Placement US$ 0.1 Mln 15
Angel Biotechnology Completes Private Placement Of US$ 1.2 Mln 16
Angel Biotechnology Completes Private Placement Of US$ 1.13 Mln 17
Angel Biotechnology Completes Private Placement Of US$ 2.6 Mln 18
Angel Biotechnology Holdings plc., Key Executives 19
Angel Biotechnology Holdings plc., Other Locations 20


List of Figures

Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Deals by Type, from 2005 to 2011 1
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Deals By Year, from 2005 to 2011 4
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Deals by Type, from 2005 to 2011 5
Angel Biotechnology Holdings plc., Pharmaceuticals and Healthcare, Merger and Acquisition Deal By Region, from 2005 to 2011 6

Companies mentioned
Celleron Therapeutics Ltd
Source BioScience Plc.
Angel Biotechnology Holdings plc.
Cypex Limited
Quanta Biotech Ltd
Alta Bioscience
Cell Medica Limited
Alba Bioscience Limited
Provita Eurotech Limited
Biosystematica

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Shadi

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers

Degenerative Disc Disease - Pipeline Review, H1 2014

Degenerative Disc Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Degenerative Disc Disease - Pipeline Review, H1 2014', provides an overview of the Degenerative Disc Disease's therapeutic ...

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Critical Limb Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

Bioheart, Inc. - Product Pipeline Review - 2014

Bioheart, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Bioheart, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Bioheart, Inc. - Product Pipeline Review - 2014', provides an overview of the Bioheart, Inc.'s pharmaceutical research ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.